To heighten the awareness of a possible association of sclerosing peritonitis in patients with systemic lupus erythematosus (SLE).
Methods and Results
Over the course of 17 years (from January 1981 to December 1997), 371 patients were treated with continuous ambulatory peritoneal dialysis (CAPD) at Rush–Presbyterian–St Lukes Medical Center. The patients were followed on CAPD for an average of 25 ± 21 (SD) months with a median of 19 months (range 0.2 – 115 months). During this time only 2 (0.5%) patients were diagnosed with sclerosing peritonitis, and both had SLE with ongoing evidence of active disease while on CAPD. With a total of 26 SLE patients being treated with CAPD during the observation period, the prevalence of sclerosing peritonitis can be said to be as high as 8% in this patient population.
Conclusion
These cases suggest that autoimmune diseases, such as SLE, that are well known to cause immune-mediated serositis may represent an additional factor predisposing to the development of sclerosing peritonitis in patients treated with CAPD.
RigbyR.J., HawleyC.M.Sclerosing peritonitis: the experience in Australia.Nephrol Dial Transplant1998; 13: 154–9.
2.
CampbellS., ClarkeP., HawleyC., WiganM., KerlinP., ButlerJ.Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features.Am J Kidney Dis1994; 24: 819–25.
3.
CoxS.V., LaiJ., SuranyiM., WalkerN.Sclerosing peritonitis with gross peritoneal calcification: a case report.Am J Kidney Dis1992; 20: 637–42.
4.
KorzetsA., KorzetsZ., PeerG., PapoJ., SternD., BernheimJ.Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen.Am J Nephrol1988; 8: 143–6.
5.
KrestinG.P., KaclG., HauserM., KeuschG., BurgerH.R., HoffmannR.Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease.Abdom Imaging1995; 20: 414–20.
6.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis (Review, 85 Refs).Perit Dial Int1992; 12: 14–27.
7.
SlingeneyerA., MionC., MouradG., CanaudB., FallerB., BeraudJ.Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis.ASAIO Trans1983; 29: 633–40.
8.
PusateriR., RossR., MarshallR., MeredithJ.H., HamiltonR.W.Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature.Am J Kidney Dis1986; 8: 56–60.
9.
NomotoY., KawaguchiY., KuboH., HiranoH., SakaiS., KurokawaK.Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.Am J Kidney Dis1996; 28: 420–7.
10.
Diaz–BuxoJ.Peritoneal sclerosis in a woman on continuous cyclic peritoneal dialysis.Semin Dial1992; 5: 317–20.
MoriY., MatsuoS., SutohH., ToriyamaT., KawaharaH., HottaN.A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone.Am J Kidney Dis1997; 30: 275–8.
13.
FerreiroJ.E., ReiterW.M., SaldanaM.J.Systemic lupus erythematosus presenting as chronic serositis with no demonstrable antinuclear antibodies.Am J Med1984; 76: 1100–5.
14.
HoffmanB.I., KatzW.A.The gastrointestinal manifestations of systemic lupus erythematosus: a review of the literature.Semin Arthritis Rheum1980; 9: 237–47.
15.
TwardowskiZ.J., AlpertM.A., GuptaR.C., NolphK.D., MadsenB.T.Circulating immune complexes: possible toxins responsible for serositis (pericarditis, pleuritis, and peritonitis) in renal failure.Nephron1983; 35: 190–5.
16.
ZizicT.M., ClassenJ.M., StevensM.B.Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa.Am J Med1982; 73: 525–30.
17.
HoutmanP.M., HofstraS.S.Lupus peritonitis presented as vague abdominal complaints in a SLE patient.Neth J Med1992; 40: 232–5.
MillerM.H., UrowitzM.B., GladmanD.D., TozmanE.C.Chronic adhesive lupus serositis as a complication of systemic lupus erythematosus. Refractory chest pain and small-bowel obstruction.Arch Intern Med1984; 144: 1863–4.
21.
RodbyR.A., KorbetS.M., LewisE.J.Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis.Am J Med1987; 83: 613–18.
22.
VergerC., CelicoutB.Peritoneal permeability and encapsulating peritonitis.Lancet1985; 1: 986–7.
23.
ShaldonS.The interleukin hypothesis: a reappraisal after 6 years.Semin Dial1989; 2: 172–5.
24.
ShaldonS., KochK., QuellhorstE., DinarelloC.Pathogenesis of sclerosing peritonitis in CAPD.ASAIO Trans1984; 30: 193–4.
25.
KredietR.T., StruijkD.G., BoeschotenE.W., KoomenG.C., StouthardJ.M.L., HoekF.J.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.Am J Kidney Dis1989; 13: 299–307.
26.
HawleyC.M., WallD.R., JohnsonD.W., CampbellS.B., GriffinA.D., RigbyR.J.Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis (see Comments).Am J Kidney Dis1995; 26: 658–61.
27.
BhandariS.Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis (Letter; Comment).Am J Kidney Dis1996; 27: 604.
